Enhanced cytoplasmic sequestration of the nuclear export receptor CRM1 by NS2 mutations developed in the host regulates parvovirus fitness

Journal of Virology

Volumn 78, Issue 19, 2004, Pages 10674-10684

  López Bueno, Alberto ^a   Valle, Noelia ^a   Gallego, Jesús M ^a,b   Pérez, Joel ^a,c   Almendral, José M ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Clinica Reyes Catolicos   (Spain)

^c University of Irvine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; ANTISERUM; CELL NUCLEUS RECEPTOR; EXPORTIN 1; LEUCINE; LYSINE; METHIONINE; NONSTRUCTURAL PROTEIN 1; POLYCLONAL ANTISERUM; PROLINE; PROTEIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; THREONINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; CONTROLLED STUDY; CYTOPLASM; DNA VIRUS; EXON; FEMALE; GENETIC HETEROGENEITY; HOST; IMMUNE DEFICIENCY; IMMUNOTHERAPY; INFECTION; LEUKOPENIA; LIFE CYCLE; MOUSE; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARTICULATE MATTER; PARVOVIRUS; PRIORITY JOURNAL; PROTECTION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; VIRULENCE; VIRUS CAPSID; VIRUS CULTURE; VIRUS ISOLATION; VIRUS STRAIN; WILD TYPE;

AMINO ACID SUBSTITUTION; ANIMALS; ANTIBODIES, VIRAL; CAPSID PROTEINS; CELL NUCLEUS; CYTOPLASM; FEMALE; IMMUNIZATION, PASSIVE; KARYOPHERINS; MICE; MICE, SCID; MINUTE VIRUS OF MICE; MUTATION, MISSENSE; NEUTRALIZATION TESTS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS; PLAQUE ASSAY; POINT MUTATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 4544241333     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.19.10674-10684.2004     Document Type: Article

References (60)

1. Adachi, Y., and M. Yanagida. 1989. Higher order chromosome structure is affected by cold-sensitive mutations in a Schizosaccharomyces pombe gene crm1+ which encodes a 115-kD protein preferentially localized in the nucleus and at its periphery. J. Cell Biol. 108:1195-1207.
2. Agbandje-McKenna, M., A. LLamas-Saiz, F. Wang, P. Tattersall, and M. G. Rossmann. 1998. Functional implications of the structure of the murine parvovirus minute virus of mice. Structure 6:1369-1381.
3. Alexandersen, S., S. Larsen, A. Cohn, A. Uttenthal, R. E. Race, B. Aasted, M. Hansen, and M. E. Bloom. 1989. Passive transfer of antiviral antibodies restricts replication of Aleutian mink disease parvovirus in vivo. J. Virol. 63:9-17.
4. Astell, C. R., M. E. Gardinerd, and P. Tattersall. 1986. DNA sequence of the lymphotropic variant of minute virus of mice, MVM(i), and comparison with the DNA sequence of the fibrotropic prototype strain. J. Virol. 57:656-669.
5. Badgett, M. R., A. Auer, L. E. Carmichael, C. R. Parrish, and J. J. Bull. 2002. Evolutionary dynamics of viral attenuation. J. Virol. 76:10524-10529.
6. Bodendorf, U., C. Cziepluch, J.-C. Jauniaux, J. Rommelaere, and N. Salome. 1999. Nuclear export factor CRM1 interacts with nonstructural proteins NS2 from parvovirus minute virus of mice. J. Virol. 73:7769-7779.
7. Bonnard, G. D., E. K. Manders, D. A. Campbell, R. B. Herberman, and M. J. Collins. 1976. Immunosuppressive activity of a subline of the mouse EL-4 lymphoma. J. Exp. Med. 143:187-205.
8. Bosma, G. C., R. P. Custer, and M. J. Bosma. 1983. A severe combined immunodeficiency mutation in the mouse. Nature 301:527-530.
9. Brockhaus, K., S. Plaza, D. J. Pintel, J. Rommelaere, and N. Salomé. 1996. Nonstructural protein NS2 of minute virus of mice associates in vivo with 14-3-3 protein family members. J. Virol 70:7527-7534.
10. Brownstein, D. G., A. L. Smith, E. A. Johnson, D. J. Pintel, L. K. Naeger, and P. Tattersall. 1992. The pathogenesis of infection with minute virus of mice depends on expression of the small nonstructural protein NS2 and on the genotype of the allotropic determinants VP1 and VP2. J. Virol. 66:3118-3124.
11. Caillet-Fauquet, P., M. Perros, A. Brandenburger, P. Spegelaere, and J. Rommelaere. 1990. Programmed killing of human cells by means of an inducible clone of parvoviral genes encoding non-structural proteins. EMBO J. 9:2989-2995.
12. Carreira, A., M. Menendez, J. Reguera, J. M. Almendral, and M. G. Mateu. 2004. In vitro disassembly of a parvovirus capsid and effect on capsid stability of heterologous peptide insertions in surface loops. J. Biol. Chem. 279:6517-6525.
13. Cater, J. E., and D. J. Pintel. 1992. The small non-structural protein NS2 of the autonomous parvovirus minute virus of mice is required for virus growth in murine cells. J. Gen. Virol. 73:1839-1843.
14. Colomar, M. C., B. Hirt, and P. Beard. 1998. Two segments in the genome of the immunosuppressive minute virus of mice determine the host-cell specificity, control viral DNA replication and affect viral RNA metabolism. J. Gen. Virol. 79:581-586.
15. Cotmore, S. F., J. D. Abramo, L. F. Carbonell, J. Bratton, and P. Tattersall. 1997. The NS2 polypeptide of parvovirus MVM is required for capsid assembly in murine cells. Virology 231:267-280.
16. Cotmore, S. F., and P. Tattersall. 1987. The autonomously replicating parvoviruses of vertebrates. Adv. Virus Res. 33:91-174.
17. Cotmore, S. F., and P. Tattersall. 1990. Alternate splicing in a parvoviral nonstructural gene links a common amino-terminal sequence to downstream domains which confer radically different localization and turnover characteristics. Virology 177:477-487.
18. Daeffler, L., R. Horlein, J. Rommelaere, and J. P. F. Nuesch. 2003. Modulation of minute virus of mice cytotoxic activities through site-directed mutagenesis within the NS coding region. J. Virol. 77:12466-12478.
19. Domingo, E., and J. J. Holland. 1997. RNA virus mutations and fitness for survival. Annu. Rev. Microbiol. 51:151-178.
20. Drake, J. W. 1991. A constant rate of spontaneous mutations in DNA-based microbes. Proc. Natl. Acad. Sci. USA 88:7160-7164.
21. Drake, J. W., and J. J. Holland. 1999. Mutation rates among RNA viruses. Proc. Natl. Acad. Sci. USA 96:13910-13913.
22. Eichwald, V., L. Daeffler, M. Klein, J. Rommelaere, and N. Salome. 2002. The NS2 proteins of parvovirus minute virus of mice are required for efficient nuclear egress of progeny virions in mouse cells. J. Virol. 76:10307-10319.
23. Eigen, M., and C. K. Biebricher. 1988. Sequence space and quasispecies distribution, p. 211-245. In E. Domingo, J. J. Holland, and P. Ahlquist (ed.), RNA genetics, vol. III. CRC Press, Boca Raton, Florida.
24. Engle, M., and M. S. Diamond. 2003. Antibody prophylaxis and therapy against west Nile virus infection in wild-type and immunodeficient mice. J. Virol. 77:12941-12949.
25. Forgues, M., A. J. Marrogi, E. A. Spillare, C.-G. Wu, Q. Yang, M. Yoshida, and X. W. Wang. 2001. Interaction of the hepatitis B virus X protein with the Crm1-dependent nuclear export pathway. J. Biol. Chem. 276:22797-22803.
26. Forgues, M., M. J. Difilippantonio, S. P. Linke, T. Ried, K. Nagashima, J. Feden, K. Valerie, K. Fukasawa, and X. W. Wang. 2003. Involvement of Crm1 in hepatitis B virus X protein-induced aberrant centriole replication and abnormal mitotic spindles. Mol. Cell. Biol. 23:5282-5292.
27. Fomerod, M., M. Ohno, M. Yoshida, and I. W. Mattaj. 1997. Crm1 is an export receptor for leucine-rich nuclear export signals. Cell 90:1051-1060.
28. Gao, G., M. R. Alvira, S. Somanathan, Y. Lu, L. H. Vandenberghe, J. J. Rux, R. Calcedo, J. Sanmignel, Z. Abbas, and J. M. Wilson. 2003. Adeno-associated viruses undergo substantial evolution in primates during natural infections. Proc. Natl. Acad. Sci. USA 100:6081-6086.
29. Gauduin, M. C., P. W. H. I. Parren, R. Weir, C. F. Barbas III, D. R. Burton, and R. A. Koup. 1997. Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1. Nat. Med. 3:1389-1393.
30. Gottschalck, E., S. Alexandersen, A. Cohn, L. A. Poulsen, M. E. Bloom, and B. Aasted. 1991. Nucleotide sequence analysis of Aleutian mink disease parvovirus shows that multiple virus types are present in infected mink. J. Virol. 65:4378-4386.
31. Holland, T. C., S. D. Marlin, M. Levine, and J. Glorioso. 1983. Antigenic variants of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies. J. Virol. 45:672-682.
32. Hwang, Y. T., B. Y. Liu, D. M. Coen, and C. B. C. Hwang. 1997. Effects of mutations in the Exo III motif of the herpes simplex virus DNA polymerase gene on enzyme activities, viral replication, and replication fidelity. J. Virol. 71:7791-7798.
33. Isnard, M., M. Granier, R. Frutos, B. Reynaud, and M. Peterschmitt. 1998. Quasispecies nature of three maize streak virus isolates obtained through different modes of selection from a population used to assess response to infection of maize cultivars. J. Gen. Virol. 79:3091-3099.
34. Keller, M. A., and E. R. Stlehm. 2000. Passive immunity in prevention and treatment of infectious diseases. Clin. Microbiol. Rev. 13:602-614.
35. Kurtzman, G. J., K. Ozawa, B. Cohen, G. Hanson, R. Oseas, and N. S. Young. 1987. Chronic bone marrow failure due to persistent B19 parvovirus infection. N. Engl. J. Med. 317:287-294.
36. López-Bueno, A., M. G. Mateu, and J. M. Almendral. 2003. High mutant frequency in populations of a DNA virus allows evasion from antibody therapy in an immunodeficient host. J. Virol. 77:2701-2708.
37. Maroto, B., N. Valle, R. Saffrich, and J. M. Almendral. 2004. Nuclear export of the nonenveloped parvovirus virion is directed by an unordered protein signal exposed on the capsid surface. J. Virol. 78:10685-10694.
38. Mascola, J. R., G. Stiegler, T. C. Van Cott, H. Katinger, C. B. Carpenter, C. E. Hansos, H. Beary, D. Hayes, S. S. Frankel, D. L. Birx, and M. G. Lewis. 2000. Protection of macaques against vaginal transmission of a pathogenic HTV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat. Med. 6:207-210.
39. McMaster, G. K., P. Beard, H. D. Engers, and B. Hirt. 1981. Characterization of an immunosuppressive parvovirus related to the minute virus of mice. J. Virol. 38:317-326.
40. Miller, C. L., and D. J. Pintel. 2002. Interaction between parvovirus NS2 protein and nuclear export factor Crm1 is important for viral egress from the nucleus of murine cells. J. Virol. 76:3257-3266.
41. Muzyczka, N., and K. I. Berns. 2001. Parvoviridae: the viruses and their replication. In D. M. Knipe et al. (ed.), Fields virology. Lippincott Williams & Wilkins, Philadelphia, Pa.
42. Naeger, L. K., J. Cater, and D. J. Pintel. 1990. The small nonstructural protein (NS2) of the parvovirus minute virus of mice is required for efficient DNA replication and infectious viras production in a cell-type-specific manner. J. Virol. 64:6166-6175.
43. Naeger, L. K., N. Salomé, and D. J. Pintel. 1993. NS2 is required for efficient translation of viral mRNA in minute viras of mice-infected murine cells. J. Virol. 67:1034-1043.
44. Neumann, G., M. T. Hughes, and Y. Kawaoka. 2000. Influenza A viras NS2 protein mediates vRNP nuclear export through NES-independent interaction with hCRM1. EMBO J. 19:6751-6758.
45. Ohshima, T., T. Nakajima, T. Oishi, N. Imamoto, Y. Moneda, A. Fukamizu, and K. Yagami. 1999. CRM1 mediates nuclear export of nonstractural protein 2 from parvoviras minute viras of mice. Biochem. Biophys. Res. Commun. 264:144-150.
46. Palladino, G., K. Mozdzanowska, G. Washko, and W. Gerhard. 1995. Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza viras pneumonia in SCID mice. J. Virol. 69:2075-2081.
47. Parrish, C. R. 1990. Emergence, natural history, and variation of canine, mink, and feline parvovirases. Adv. Virus Res. 38:403-450.
48. Parrish, C. R., C. F. Aquadro, M. L. Strassheim, J. F. Evermann, J.-Y. Sgro, and H. O. Mohammed. 1991. Rapid antigenic-type replacement and DNA sequence evolution of canine parvovirus. J. Virol. 65:6544-6552.
49. Poignard, P., R. Sabbe, G. R. Picchio, M. Wang, R. J. Gulizia, H. Katinger, P. W. H. I. Parren, D. E. Mosier, and D. R. Burton. 1999. Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo. Immunity 10:431-438.
50. Ron, D., and J. Tal. 1985. Coevolution of cells and virus as a mechanism for the persistence of lymphotropic minute viras of mice in L cells. J. Virol. 55:424-430.
51. Segovia, J. C., A. Real, J. A. Bueren, and J. M. Almendral. 1991. In vitro myelosuppressive effects of the parvovirus minute virus of mice (MVMi) on hematopoietic stem and committed progenitor cells. Blood 77:980-988.
52. Segovia, J. C., G. Guenechea, J. M. Gallego, J. M. Almendral, and J. A. Bueren. 2003. Parvovirus infection suppresses long-term repopulating hematopoietic stem cells. J. Virol. 77:8495-8503.
53. Segovia, J. C., J. M. Gallego, J. A. Bueren, and J. M. Almendral. 1999. Severe leukopenia and dysregulated erythropoiesis in SCID mice persistently infected with the parvovirus minute virus of mice. J. Virol. 73:1774-1784.
54. Soliman, T. M., and S. J. Silverstein. 2000. Herpesvirus mRNAs are sorted for export via Crm1-dependent and -independent pathways. J. Virol. 74:2814-2825.
55. Tattersall, P., and J. Bratton. 1983. Reciprocal productive and restrictive virus-cell interaction of immunosuppressive and prototype strains of minute virus of mice. J. Virol. 46:944-955.
56. Truyen, U., A. Gruemberg, S.-F. Chang, B. Obermaier, P. Verjalainen, and C. R. Parrish. 1995. Evolution of the feline-subgroup parvoviruses and the control of canine host range in vivo. J. Virol. 69:4702-4710.
57. Villarreal, L. P., and V. R. De Filippis. 2001. Virus evolution. In D. M. Knipe et al. (ed.), Fields virology. Lippincott Williams & Wilkins, Philadelphia, Pa.
58. Wichman, H. A., M. R. Badgett, L. A. Scott, C. M. Boulianne, and J. J. Bull. 1999. Different trajectories of parallel evolution during viral adaptation. Science 285:422-424.
59. Young, P. J., K. T. Jensen, L. R. Burger, D. J. Pintel, and C. L. Lorson. 2002. Minute vims of mice small nonstructural protein NS2 interacts and colocalizes with the Smn protein. J. Virol. 76:6364-6369.
60. Zwíck, M. B., M. Wang, P. Poignard, G. Stiegler, H. Katinger, D. R. Burton, and P. W. H. I. Parren. 2001. Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies. J. Virol. 75:12198-12208.